(Q73363967)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735130%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735130%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

main subject

hepatocellular carcinoma

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12735130

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00082-0

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00082-0

31 December 2023

Etsuro Hatano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735130%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Iwao Ikai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735130%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Yuzo Yamamoto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735130%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Naritaka Yamamoto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735130%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Hiroaki Terajima

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735130%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Yasuyuki Shimahara

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735130%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Yoshio Yamaoka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735130%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12735130

31 December 2023

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735130%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

3 November 2019

https://api.elsevier.com/content/article/PII:S1055320702000820?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S1055-3207(02)00082-0

https://api.elsevier.com/content/article/PII:S1055320702000820?httpAccept=text/plain

31 December 2023

1 reference

DOI

https://api.crossref.org/works/10.1016/S1055-3207(02)00082-0

Surgical oncology clinics of North America

31 December 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735130%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735130%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735130%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

65-75, ix

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735130%20AND%20SRC:MED&resulttype=core&format=json

Hepatocellular carcinoma: Recent progress

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Postresection recurrence of hepatocellular carcinoma treated by arterial embolization: analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Transcatheter arterial chemoembolization (TACE) in the treatment of unresectable liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Response of hepatic mitochondrial redox state to oral glucose load. Redox tolerance test as a new predictor of surgical risk in hepatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Total vascular exclusion for hepatic resection in cirrhotic patients. Application of venovenous bypass

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Changes in arterial ketone body ratio in the phase immediately after hepatectomy. Prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Metabolic abnormalities associated with postoperative organ failure. A redox theory

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver Cancer Study Group of Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Impaired liver function and long‐term prognosis after hepatectomy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900082-0

7 January 2021

Clinical experience with 118 hepatic resections for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(02)00082-0

31 December 2023

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735130%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12735130%20AND%20SRC:MED&resulttype=core&format=json